BOSTON SCIENTIFIC CORPORATION Increase (Decrease) in Other Operating Assets
BOSTON SCIENTIFIC CORPORATION (BSX) reported Increase (Decrease) in Other Operating Assets of $90.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$19.00M, a 161.29% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $109.00M, a 41.56% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$18.00M, a 205.88% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$5.00M.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating assets for fiscal 2025 was $85.00M, a 32.54% decline from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating assets for fiscal 2024 was $126.00M.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating assets for fiscal 2023 was -$10.00M, a 104.78% decline from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in other operating assets for fiscal 2022 was $209.00M, a 55.97% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $90.00M 10-Q · filed 2026-08-03 | $72.00M derived: sum of 3 quarters · filed 2026-08-03 | $67.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2026-03-31 | $109.00M 10-Q · filed 2026-05-01 | $91.00M derived: sum of 2 quarters · filed 2026-05-01 | $86.00M derived: sum of 3 quarters · filed 2026-05-01 | $117.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-12-31 | -$18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$23.00M derived: sum of 2 quarters · filed 2026-02-17 | $8.00M derived: sum of 3 quarters · filed 2026-08-03 | $85.00M 10-K · filed 2026-02-17 | |
| 2025-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $26.00M derived: sum of 2 quarters · filed 2026-08-03 | $103.00M 10-Q · filed 2025-11-03 | $120.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-06-30 | $31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $108.00M 10-Q · filed 2026-08-03 | $125.00M derived: sum of 3 quarters · filed 2026-08-03 | $108.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $77.00M 10-Q · filed 2026-05-01 | $94.00M derived: sum of 2 quarters · filed 2026-05-01 | $77.00M derived: sum of 3 quarters · filed 2026-05-01 | $148.00M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $71.00M derived: sum of 3 quarters · filed 2026-02-17 | $126.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | -$17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $54.00M derived: sum of 2 quarters · filed 2025-11-03 | $109.00M 10-Q · filed 2025-11-03 | $56.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | $71.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $126.00M 10-Q · filed 2025-08-01 | $73.00M derived: sum of 3 quarters · filed 2026-02-17 | $61.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-03-31 | $55.00M 10-Q · filed 2025-05-01 | $2.00M derived: sum of 2 quarters · filed 2026-02-17 | -$10.00M derived: sum of 3 quarters · filed 2026-02-17 | $4.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2023-12-31 | -$53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$65.00M derived: sum of 2 quarters · filed 2026-02-17 | -$51.00M derived: sum of 3 quarters · filed 2026-02-17 | -$10.00M 10-K · filed 2026-02-17 | |
| 2023-09-30 | -$12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $2.00M derived: sum of 2 quarters · filed 2024-11-01 | $43.00M 10-Q · filed 2024-11-01 | -$46.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-06-30 | $14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $55.00M 10-Q · filed 2024-08-01 | -$34.00M derived: sum of 3 quarters · filed 2025-02-18 | $20.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-03-31 | $41.00M 10-Q · filed 2024-05-01 | -$48.00M derived: sum of 2 quarters · filed 2025-02-18 | $6.00M derived: sum of 3 quarters · filed 2025-02-18 | $110.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2022-12-31 | -$89.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$35.00M derived: sum of 2 quarters · filed 2025-02-18 | $69.00M derived: sum of 3 quarters · filed 2025-02-18 | $209.00M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $54.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $158.00M derived: sum of 2 quarters · filed 2023-11-01 | $298.00M 10-Q · filed 2023-11-01 | $287.00M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-06-30 | $104.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $244.00M 10-Q · filed 2023-08-03 | $233.00M derived: sum of 3 quarters · filed 2024-02-20 | $178.00M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-03-31 | $140.00M 10-Q · filed 2023-05-04 | $129.00M derived: sum of 2 quarters · filed 2024-02-20 | $74.00M derived: sum of 3 quarters · filed 2024-02-20 | $146.00M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2021-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$66.00M derived: sum of 2 quarters · filed 2024-02-20 | $6.00M derived: sum of 3 quarters · filed 2024-02-20 | $134.00M 10-K · filed 2024-02-20 | |
| 2021-09-30 | -$55.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $17.00M derived: sum of 2 quarters · filed 2022-11-03 | $145.00M 10-Q · filed 2022-11-03 | $291.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $72.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $200.00M 10-Q · filed 2022-08-04 | $346.00M derived: sum of 3 quarters · filed 2023-02-23 | $286.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $128.00M 10-Q · filed 2022-05-05 | $274.00M derived: sum of 2 quarters · filed 2023-02-23 | $214.00M derived: sum of 3 quarters · filed 2023-02-23 | $265.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $146.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $86.00M derived: sum of 2 quarters · filed 2023-02-23 | $137.00M derived: sum of 3 quarters · filed 2023-02-23 | $265.00M 10-K · filed 2023-02-23 | $200.00M 10-K · filed 2021-02-23 |
| 2020-09-30 | -$60.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$9.00M derived: sum of 2 quarters · filed 2021-11-04 | $119.00M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $51.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $179.00M 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | $128.00M 10-Q · filed 2021-05-06 | ||||
| 2019-12-31 | -$45.00M 10-K · filed 2022-02-23 | ||||
| 2018-12-31 | $172.00M 10-K · filed 2021-02-23 | ||||
| 2017-12-31 | $20.00M 10-K · filed 2020-02-25 | ||||
| 2016-12-31 | $43.00M 10-K · filed 2019-02-19 | $253.00M 10-K · filed 2017-02-23 | |||
| 2015-12-31 | -$23.00M 10-K · filed 2018-02-20 | $23.00M 10-K · filed 2016-02-24 | |||
| 2014-12-31 | $33.00M 10-K · filed 2017-02-23 | ||||
| 2013-12-31 | -$91.00M 10-K · filed 2016-02-24 | ||||
| 2012-12-31 | $68.00M 10-K · filed 2015-02-25 | ||||
| 2011-12-31 | $60.00M 10-K · filed 2014-02-26 | ||||
| 2010-12-31 | -$132.00M 8-K · filed 2013-05-29 | ||||
| 2009-12-31 | -$276.00M 10-K · filed 2012-02-17 | $276.00M 10-K · filed 2010-02-26 | |||
| 2008-12-31 | $21.00M 10-K · filed 2011-02-17 | -$21.00M 10-K · filed 2010-02-26 | |||
| 2007-12-31 | -$43.00M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |